Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Lornoxicam (8mg) + Paracetamol (325mg)
Therapeutic Category
Anti-Inflammatories, Antipyretics, General and OTC medicines, Analgesics, Orthopedics, Rheumatology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹130/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Loxifrit P Tablet is a combination of Lornoxicam (8mg) and Paracetamol (325mg), designed to provide effective pain relief and reduce inflammation. Lornoxicam belongs to the non-steroidal anti-inflammatory drugs (NSAIDs) category and works by inhibiting prostaglandin synthesis, which is responsible for pain and inflammation. Paracetamol complements this action by providing analgesic and antipyretic effects, making the combination highly effective in managing pain and fever associated with various conditions.
This formulation is widely prescribed for the symptomatic relief of mild to moderate pain, including musculoskeletal disorders, postoperative pain, dental pain, and osteoarthritis. It also helps reduce inflammation, making it suitable for conditions where swelling and discomfort coexist. The combination of Lornoxicam and Paracetamol ensures comprehensive relief by targeting both the inflammatory and central pain pathways.
The dual-action mechanism of Loxifrit P Tablet offers fast and long-lasting relief, improving patient compliance and quality of life. It is recommended to take this medication with or after meals to minimize gastrointestinal side effects commonly associated with NSAIDs.
Common side effects may include nausea, vomiting, abdominal discomfort, heartburn, and dizziness. In rare cases, patients may experience gastrointestinal bleeding, skin rash, or allergic reactions. Prolonged use or overdose may affect liver or kidney function.
Relief from mild to moderate pain due to musculoskeletal conditions, dental pain, or postoperative discomfort. Management of inflammatory conditions, including arthritis and osteoarthritis. Reduction of fever and associated symptoms.
Do not use this medication if you are allergic to Lornoxicam, Paracetamol, or NSAIDs. Avoid alcohol consumption while using this medication to prevent liver damage. Consult a doctor if you are pregnant, breastfeeding, or have pre-existing liver, kidney, or gastrointestinal conditions.
Store Loxifrit P Tablet in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children and do not use the medication past its expiration date.
Composition : Mefenamic Acid (500mg) + Paracetamol (325mg)
Composition : Tolperisone (150mg) + Paracetamol (325mg)
Composition : Thiocolchicoside (4mg) + Aceclofenac (100mg) + Paracetamol (325mg) Tablet
Composition : Tolperisone (150mg) + Diclofenac (50mg)
Composition : Tolperisone (450mg) + Diclofenac (100mg)
Composition : Clomiphene (100mg)
Composition : Clomiphene (25mg) Tablet
Composition : Clomiphene (50mg)
Composition : Solifenacin (10mg) Tablet
Composition : Mirabegron (25mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination tablet has strong demand in the pain management, orthopedics, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on analgesic and anti-inflammatory portfolios.
Medical distributors and agencies can benefit from consistent demand for pain and inflammation management under medical supervision. Lornoxicam 8mg is a non-steroidal anti-inflammatory drug (NSAID) that helps reduce pain and inflammation Paracetamol 325mg provides effective analgesic and antipyretic support The combination is commonly prescribed for musculoskeletal pain, joint disorders, post-operative pain, and inflammatory conditions This strengthens a reliable pain-management and orthopedic portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Lornoxicam 8mg + Paracetamol 325mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong demand among orthopedicians and general physicians, consistent retail movement, repeat prescriptions, reliable supply chain support, and good margins in pain-management medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality products, and a dependable supply chain to grow their pharmaceutical business successfully.